Imperial College London
Portrait Picture

Dr Andrea Rodriguez Martinez

Faculty of Medicine, School of Public Health

Honorary Research Associate
 
 
 
//

Contact

 

andrea.rodriguez-martinez13

 
 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Zhou:2019:10.1016/S0140-6736(19)31145-6,
author = {Zhou, B and Danaei, G and Stevens, GA and Bixby, H and Taddei, C and Carrillo, Larco R and Solomon, B and Riley, LM and Di, Cesare M and Iurilli, N and Rodriguez, Martinez A and Zhu, A and Hajifathalian, K and Amuzu, A and Banegas, JR and Bennett, JE and Cameron, C and Cho, Y and Clarke, J and Craig, CL and Cruz, JJ and Gates, L and Giampaoli, S and Gregg, EW and Hardy, R and Hayes, AJ and Ikeda, N and Jackson, RT and Jennings, G and Joffres, M and Khang, Y-H and Koskinen, S and Kuh, D and Kujala, UM and Laatikainen, T and Lehtimaki, T and Lopez-Garcia, E and Lundqvist, A and Maggi, S and Magliano, DJ and Mann, JI and McLean, RM and McLean, SB and Miller, JC and Morgan, K and Neuhauser, HK and Niiranen, TJ and Noale, M and Oh, K and Palmieri, L and Panza, F and Parnell, WR and Peltonen, M and Raitakari, O and Rodriguez-Artalejo, F and Roy, JGR and Salomaa, V and Sarganas, G and Servais, J and Shaw, JE and Shibuya, K and Solfrizzi, V and Stavreski, B and Tan, EJ and Turley, ML and Vanuz},
doi = {10.1016/S0140-6736(19)31145-6},
journal = {Lancet},
pages = {639--651},
title = {Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys},
url = {http://dx.doi.org/10.1016/S0140-6736(19)31145-6},
volume = {394},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Background:  Antihypertensive  medicines  are effective in  reducing  adverse  cardiovascular  events. Our aim was to compare hypertension awareness, treatment and control, and how they have changed over time, in high-income countries. Methods:  We  used  data  on  526,336 participants  aged  40-79  years  in  123 national  health  examination surveys from 1976 to 2017 in twelve high-income countries: Australia, Canada, Finland,  Germany,  Ireland,  Italy,  Japan,  New  Zealand,  South  Korea,  Spain,  the  UK,  and  the  USA. We calculated the percent of participants with hypertension – defined as systolic blood pressure  ≥140mmHg  or  diastolic  blood  pressure  ≥90mmHg  or  being  on  pharmacological  treatment for hypertension – who were aware of their condition, who were treated, and whose hypertension was controlled (i.e. lower than 140/90 mmHg).   Findings:  Canada,  South  Korea,  Australia  and  the  UK  have the  lowest  prevalence  of  hypertension,  and  Finland  the  highest.  In  the  1980s  and  early  1990s,  treatment  rates  were  at  most 40% and control rates were below 25% in most countries and age-sex groups. Over time, hypertension  awareness  and  treatment  increased  and  control  rate  improved  in  all  twelve  countries, with South Korea and Germany experiencing the largest improvements. Most of the increase occurred in the 1990s and early-mid 2000s, having plateaued since in most countries.Canada, Germany,  South  Korea  and  the  USA  have the  highest  rates  of  awareness,  treatment  and control, while Finland,  Ireland, Japan and Spain the lowest. Even in the best performing countries, treatment coverage was at most 80% and control rates were below 70%.  Interpretation:  Hypertension awareness,  treatment  and  control  have  improved  substantially  in high-income countries since the 1980s and 1990s. However, control rates have plateaued in the past decade, at levels lower than those in high-quality hypertension
AU  - Zhou,B
AU  - Danaei,G
AU  - Stevens,GA
AU  - Bixby,H
AU  - Taddei,C
AU  - Carrillo,Larco R
AU  - Solomon,B
AU  - Riley,LM
AU  - Di,Cesare M
AU  - Iurilli,N
AU  - Rodriguez,Martinez A
AU  - Zhu,A
AU  - Hajifathalian,K
AU  - Amuzu,A
AU  - Banegas,JR
AU  - Bennett,JE
AU  - Cameron,C
AU  - Cho,Y
AU  - Clarke,J
AU  - Craig,CL
AU  - Cruz,JJ
AU  - Gates,L
AU  - Giampaoli,S
AU  - Gregg,EW
AU  - Hardy,R
AU  - Hayes,AJ
AU  - Ikeda,N
AU  - Jackson,RT
AU  - Jennings,G
AU  - Joffres,M
AU  - Khang,Y-H
AU  - Koskinen,S
AU  - Kuh,D
AU  - Kujala,UM
AU  - Laatikainen,T
AU  - Lehtimaki,T
AU  - Lopez-Garcia,E
AU  - Lundqvist,A
AU  - Maggi,S
AU  - Magliano,DJ
AU  - Mann,JI
AU  - McLean,RM
AU  - McLean,SB
AU  - Miller,JC
AU  - Morgan,K
AU  - Neuhauser,HK
AU  - Niiranen,TJ
AU  - Noale,M
AU  - Oh,K
AU  - Palmieri,L
AU  - Panza,F
AU  - Parnell,WR
AU  - Peltonen,M
AU  - Raitakari,O
AU  - Rodriguez-Artalejo,F
AU  - Roy,JGR
AU  - Salomaa,V
AU  - Sarganas,G
AU  - Servais,J
AU  - Shaw,JE
AU  - Shibuya,K
AU  - Solfrizzi,V
AU  - Stavreski,B
AU  - Tan,EJ
AU  - Turley,ML
AU  - Vanuzzo,D
AU  - Viikari-Juntura,E
AU  - Weerasekera,D
AU  - Ezzati,M
DO  - 10.1016/S0140-6736(19)31145-6
EP  - 651
PY  - 2019///
SN  - 0140-6736
SP  - 639
TI  - Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys
T2  - Lancet
UR  - http://dx.doi.org/10.1016/S0140-6736(19)31145-6
UR  - http://hdl.handle.net/10044/1/70337
VL  - 394
ER  -
Download